Related Experiment Video
Updated: Oct 17, 2025

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Prognostic Association Between Perioperative Red Blood Cell Transfusion and Postoperative Cardiac Surgery Outcomes
Yanxiu Li1, Iokfai Cheang2, Zhongwen Zhang3
1Department of Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Insights
Red blood cell transfusions in cardiac surgery patients are linked to worse outcomes, including higher mortality rates. A restricted transfusion strategy may improve prognosis for selected patients.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Critical Care Medicine
Background:
- Red blood cell transfusion is common in cardiac surgery.
- The impact of perioperative transfusion on patient outcomes requires further investigation.
Purpose of the Study:
- To examine the association between red blood cell transfusion and clinical outcomes in patients undergoing cardiac surgery.
- To determine if perioperative transfusion independently predicts mortality after cardiac surgery.
Main Methods:
- Retrospective analysis of 6,752 cardiac surgery patients from the MIMIC-III database.
- Multivariable logistic regression was used to adjust for confounding factors.
- Patients were stratified into transfusion and no-transfusion groups.
Main Results:
- 40.9% of patients received perioperative red blood cell transfusion.
- Transfused patients had significantly higher in-hospital, 1-year, and long-term mortality.
- Adjusted analysis confirmed transfusion as an independent predictor of increased mortality (ORs ranging from 2.0 to 2.8).
Conclusions:
- Perioperative red blood cell transfusion is associated with poorer prognosis in cardiac surgery patients.
- Consideration of optimal perioperative management and restrictive transfusion strategies is recommended for selected patients.
Abstract:
Objective: To investigate the correlation between red blood cell transfusion and clinical outcome in patients after cardiac surgery. Methods: Demographic, clinical characteristics, treatment with/without transfusion, and outcomes of patients after cardiac surgery from the Medical Information Mart for Intensive Care-III database were collected. Patients were divided into two groups according to perioperative transfusion. A multivariable logistic regression analysis was utilized to adjust for the effect of red blood cell transfusion on outcomes for baseline and covariates and to determine its association with outcomes. Results: In total, 6,752 patients who underwent cardiac surgery were enrolled for the analysis. Among them, 2,760 (40.9%) patients received a perioperative transfusion. Compared with patients without red blood cell transfusion, transfused patients demonstrated worse outcomes in inhospital mortality, 1-year mortality, and all-cause mortality. Adjusting odds ratios (ORs) for the significant characteristic, patients with perioperative transfusion remained significantly associated with an increased risk of inhospital mortality [OR = 2.8, 95% confidence interval (CI) 1.5-5.1, P = 0.001], 1-year mortality (OR = 2.0, 95% CI 1.4-2.7, P < 0.001), and long-term mortality (OR = 2.2, 95% CI 1.8-2.8, P < 0.001). Conclusion: Perioperative red blood cell transfusion is associated with a worse prognosis of cardiac surgery patients. Optimal perioperative management and restricted transfusion strategy might be considered in selected patients.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

